Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management
As osteoporosis treatment continues to evolve, clinicians are moving beyond bone mineral density scores alone and placing greater emphasis on fracture risk when making therapeutic decisions. While antiresorptive medications remain a cornerstone of treatment, emerging evidence is reshaping how providers identify high-risk patients and determine when more aggressive intervention may be warranted.
April Tschumy, APRN, ONP-C
According to April Tschumy, APRN, ONP-C, metabolic bone specialist with Baptist Health Orthopedic Care's Bone Health and Fracture Prevention Program, advances in risk stratification and bone-building therapies are changing the treatment landscape, particularly for patients with a history of fragility fractures.
Osteoporosis Is More Than a Bone Density Diagnosis
Dual-energy X-ray absorptiometry (DXA) remains the gold standard for osteoporosis screening and treatment monitoring. Current guidelines recommend screening for women age 65 and older and men age 70 and older. But many patients warrant earlier evaluation based on individual risk factors.
Patients who may benefit from earlier screening include:
- Individuals with a personal history of low-energy or fragility fractures
- Patients receiving hormone-suppressing therapies for breast, ovarian or prostate cancer
- Individuals with a family history of osteoporosis
- Patients with conditions or treatments known to accelerate bone loss
“Many patients qualify for screening well before the traditional age thresholds,” Ms. Tschumy says. “Identifying bone loss early allows us to intervene before a fracture occurs.”
Risk assessment has become increasingly important as clinicians recognize that patients with similar bone density scores may have markedly different fracture risks.
Fracture History Has Become a Critical Treatment Consideration
A prior fragility fracture remains one of the strongest predictors of future fracture risk.
Patients who sustain hip fractures, vertebral compression fractures or other low-energy fractures face a significantly increased risk of subsequent fractures. As a result, osteoporosis management is increasingly focused on preventing secondary fractures before they occur.
“We've learned that not all osteoporosis patients should be managed the same way,” Ms. Tschumy says. “The patient's fracture history and future fracture risk should help determine whether we focus on slowing bone loss or actively building bone.”
This shift has led clinicians to distinguish between patients at high risk and those at very high risk for fracture, with treatment strategies tailored accordingly.
Why Treatment Selection Is Changing
Bone remodeling depends on a balance between osteoclasts, which break down bone, and osteoblasts, which build new bone.
Historically, most patients were started on oral antiresorptive therapies designed to reduce bone resorption. While these medications remain effective for many individuals, growing evidence suggests that patients at very high fracture risk may benefit from an anabolic-first approach.
“Fifteen years ago, nearly everyone started with oral medications,” Ms. Tschumy says. “Today, patients who are considered very high risk often benefit from bone-building therapies first because we know they can reduce fracture risk more quickly.”
This evolving treatment paradigm reflects a broader emphasis on fracture prevention rather than simply improving bone density measurements.
The Expanding Role of Bone-Building Therapies
Advances in osteoporosis therapeutics have expanded options for patients with severe osteoporosis or prior fragility fractures.
Depending on patient characteristics and treatment goals, therapy may include:
- Oral antiresorptive medications
- Intravenous infusion therapies
- Monthly or semiannual injectable treatments
- Anabolic agents that stimulate new bone formation
Selection depends on multiple factors, including fracture history, baseline risk, comorbidities and patient preferences.
“There isn't a one-size-fits-all approach,” Ms. Tschumy says. “We review each patient's fracture risk, medical history and treatment goals, and then work together to choose the best option.”
Infusion Therapies Offer Additional Treatment Pathways
While infusion centers are often associated with oncology care, infusion-based therapies play an increasingly important role in osteoporosis management.
For patients who cannot tolerate oral medications, have gastrointestinal contraindications or require bone building treatment, infusion and injectable therapies provide additional options.
Most osteoporosis infusions do not require central venous access and can typically be completed in approximately one hour. Depending on the medication selected, treatment schedules may range from monthly administration to once-yearly infusions.
Importantly, treatment decisions should remain individualized, balancing efficacy, convenience and patient adherence.
Monitoring Treatment Response
Successful osteoporosis management requires ongoing assessment rather than a one-time intervention.
Clinicians may monitor response through:
- Follow-up DXA testing
- Bone turnover markers
- Laboratory evaluation
- Fracture surveillance
- Functional outcomes
Not all patients respond similarly to a given therapy, making reassessment an essential component of care.
“If a patient isn't responding the way we expect, that doesn't mean we've run out of options,” Ms. Tschumy says. “It means we need to reevaluate and consider a different therapeutic pathway.”
Fracture Prevention Remains the Ultimate Goal
For many patients, the greatest consequence of osteoporosis is not declining bone density but loss of independence after a major fracture.
Hip fractures remain associated with significant morbidity and mortality despite advances in surgical management. Vertebral fractures similarly increase the likelihood of future fractures, chronic pain and functional decline.
Ms. Tschumy emphasizes that preventing these outcomes remains the central objective of treatment.
“Our goal is to reduce fracture risk, maintain independence and help patients preserve their level of function,” she says.
Early identification and treatment may be particularly important for patients who have already sustained a fragility fracture, as timely intervention can substantially reduce the likelihood of subsequent fractures.
Lifestyle Optimization Still Matters
Pharmacologic treatment is only one component of comprehensive bone health management.
Patients should also be counseled on:
- Adequate dietary calcium intake
- Maintaining sufficient vitamin D levels
- Progressive resistance and strength training
- Fall prevention strategies
- Avoiding prolonged sedentary behavior
Resistance-based exercise remains especially important because mechanical loading stimulates bone formation and helps preserve skeletal strength over time.
“Exercise is one of the few interventions proven to help reverse bone loss,” Ms. Tschumy says. “Strength training and resistance exercises create the stimulus bones need to maintain and rebuild strength.”
Looking Ahead
As osteoporosis care continues to evolve, clinicians are increasingly focusing on identifying patients at elevated fracture risk before life-changing fractures occur.
Advances in risk stratification, expanding use of anabolic therapies and a growing emphasis on secondary fracture prevention are reshaping how osteoporosis is managed across specialties.
“The future looks very promising because we now have treatments that can dramatically reduce fracture risk in high-risk patients,” Ms. Tschumy says. “The earlier we identify those patients, the greater opportunity we have to prevent fractures and preserve independence.”
As evidence continues to emerge, personalized treatment selection and proactive fracture prevention are likely to remain central themes in osteoporosis care.
Refer a Patient
Baptist Health Orthopedic Care's Bone Health and Fracture Prevention Program offers comprehensive osteoporosis evaluation, fracture risk assessment and advanced treatment options, including infusion and bone-building therapies. Learn more about referral pathways and available resources through Baptist Health Orthopedic Care.
